Enhancement of radiosensitivity by 5-Aza-CdR through activation of G2/M checkpoint response and apoptosis in osteosarcoma cells (Q39029463)

8 September 2017

title

Enhancement of radiosensitivity by 5-Aza-CdR through activation of G2/M checkpoint response and apoptosis in osteosarcoma cells (English)

1 reference

8 September 2017

Yi Li

1

1 reference

8 September 2017

PeiLiang Geng

2

1 reference

8 September 2017

Weihao Jiang

3

1 reference

8 September 2017

Yunlai Wang

4

1 reference

8 September 2017

Jie Yao

5

1 reference

8 September 2017

Xu Lin

6

1 reference

8 September 2017

Jun Liu

7

1 reference

8 September 2017

Lichun Huang

8

1 reference

8 September 2017

Bin Su

9

1 reference

8 September 2017

Hong Chen

10

1 reference

8 September 2017

publication date

29 January 2014

1 reference

8 September 2017

1 reference

8 September 2017

volume

35

1 reference

8 September 2017

issue

5

1 reference

8 September 2017

page(s)

4831-4839

1 reference

Aberrant epigenetic regulation: a central contributor to lung carcinogenesis and a new therapeutic target

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1634-5

Cancer epigenetics: a brief review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1634-5

DNA Demethylating Agents and Epigenetic Therapy of Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1634-5

Mutations in epigenetic modifiers in myeloid malignancies and the prospect of novel epigenetic-targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1634-5

The role of mutations in epigenetic regulators in myeloid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1634-5

Pharmacokinetic and pharmacodynamic analysis of 5-aza-2'-deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1634-5

The combination effect of sodium butyrate and 5-Aza-2'-deoxycytidine on radiosensitivity in RKO colorectal cancer and MCF-7 breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1634-5

Relationship between clonogenic radiosensitivity, radiation-induced apoptosis and DNA damage/repair in human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1634-5

Changes in genomic imprinting and gene expression associated with transformation in a model of human osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1634-5

Regulation of 14-3-3sigma expression in human thyroid carcinoma is epigenetically regulated by aberrant cytosine methylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1634-5

Methylation of the APAF-1 and DAPK-1 promoter region correlates with progression of renal cell carcinoma in North Indian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1634-5

Chk2 down-regulation by promoter hypermethylation in human bulk gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1634-5

Cancer epigenetics: from mechanism to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1634-5

DNA methyltransferase inhibitor 5-aza-CdR enhances the radiosensitivity of gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1634-5

Enhancement of in vitro and in vivo tumor cell radiosensitivity by the DNA methylation inhibitor zebularine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1634-5

A systematic assessment of radiation dose enhancement by 5-Aza-2'-deoxycytidine and histone deacetylase inhibitors in head-and-neck squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1634-5

DNMT (DNA methyltransferase) inhibitors radiosensitize human cancer cells by suppressing DNA repair activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1634-5

Genome-wide transcriptome profile of the human osteosarcoma Sa OS and U-2 OS cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1634-5

Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1634-5

Strategies to improve radiotherapy with targeted drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1634-5

Decitabine, a DNA methyltransferases inhibitor, induces cell cycle arrest at G2/M phase through p53-independent pathway in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1634-5

Evolution of decitabine development: accomplishments, ongoing investigations, and future strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1634-5

Downregulation of 14-3-3sigma in ovary, prostate and endometrial carcinomas is associated with CpG island methylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1634-5

14-3-3sigma gene silencing during melanoma progression and its role in cell cycle control and cellular senescence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1634-5

14-3-3 proteins in cell cycle regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1634-5

14-3-3σ mediates G2-M arrest produced by 5-aza-2'-deoxycytidine and possesses a tumor suppressor role in endometrial carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1634-5

Histone deacetylase inhibitor and demethylating agent chromatin compaction and the radiation response by cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1634-5

DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1634-5

Review of therapeutic strategies for osteosarcoma, chondrosarcoma, and Ewing's sarcoma

21 January 2018

1 reference

12 December 2020

Promoter hypermethylation of p16INK4a, E-cadherin, O6-MGMT, DAPK and FHIT in adenocarcinomas of the esophagus, esophagogastric junction and proximal stomach.

1 reference

12 December 2020

Promoter methylation of death-associated protein kinase and its role in irradiation response in cervical cancer.

1 reference

12 December 2020

Pharmacological genome demethylation increases radiosensitivity of head and neck squamous carcinoma cells

1 reference

12 December 2020

[Ionizing radiation-induced DNA damage and repair]

1 reference

12 December 2020

The influence of chromatin structure on the frequency of radiation-induced DNA strand breaks: a study using nuclear and nucleoid monolayers

1 reference

12 December 2020

Cyclic x-ray responses in mammalian cells in vitro

1 reference

12 December 2020

Osteosarcoma treatment: state of the art.

1 reference

12 December 2020

10.1007/S13277-014-1634-5

Identifiers

DOI

1 reference

8 September 2017

1 reference